demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID 19 hospitalized
tofacitinib STOP-COVID ...

1 studies excluded by filtering options 0

9258 Murugesan, 2022 110risk of bias not avaialble